Minot Wealth Management’s Gilead Sciences GILD Stock Holding History

Minot Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,928	Closed	-$234K	–	197
2022 Q1	$234K	Buy	3,928 +953	+32%	+$60.9K	0.05%	179
2021 Q4	$216K	Sell	2,975 -687	-19%	-$47.3K	0.04%	186
2021 Q3	$256K	Buy	+3,662	New	+$257K	0.06%	171
2021 Q2	–	Sell	-12,696	Closed	-$821K	–	215
2021 Q1	$821K	Buy	+12,696	New	+$819K	0.21%	100
2020 Q4	–	Sell	-35,210	Closed	-$2.23M	–	161
2020 Q3	$2.23M	Buy	35,210 +3,498	+11%	+$243K	0.84%	50
2020 Q2	$2.44M	Buy	31,712 +11,477	+57%	+$880K	1.22%	33
2020 Q1	$1.51M	Buy	+20,235	New	+$1.4M	1.08%	34

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Minot Wealth Management's GILD Position: Q2 2022 in Review

Minot Wealth Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 3,928 shares — an estimated $234K sold.

Minot Wealth Management first reported a position in GILD in Q1 2020 and held it in 7 quarters. The position peaked at $2.44M in Q2 2020. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Minot Wealth Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
Minot Wealth Management sold 3,928 Gilead Sciences shares in Q2 2022, an estimated $234K.
Minot Wealth Management first reported a position in Gilead Sciences in Q1 2020 and held it in 7 quarters.
Minot Wealth Management's Gilead Sciences position peaked at $2.44M in Q2 2020.
1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.